Dermapharm has acquired Arkopharma SE from Montagu Private Equity LLP.

We acted as advisor to the buyer.

Dermazentrum sold a majority ownership stake in an Owners Buy-out to Halder.

We advised Dermazentrum and its founder.

Vitafy Brands and EVP Group have merged.

We acted as advisor to Vitafy Brands and its shareholders.

Dermapharm has acquired C3 – Cannabinoid Compound Company GmbH from Canopy Growth Corporation.

We acted as advisor to the buyer.

Wellster Healthtech successfully completed a USD 40m private placement led by a group of investors.

We advised and supported Wellster Healthtech in its funding round.

Oakley Capital has acquired WindStar Medical GmbH from ProSiebenSat.1 majority-owned NuCom Group.

We acted as advisor to the buyer.

Permira Beteiligungsberatung has acquired Neuraxpharm from Apax Partners.

We acted as advisor to the buyer.

The Apotal group has sold its mail-order pharmaceuticals and diabetes activities to Zur Rose group.

We initiated the transaction and acted as advisor to Heinz-Peter Fichter and Apotal group.

Dermapharm has acquired Allergopharma GmbH & Co. KG, a subsidiary of Merck KGaA.

We acted as advisor to the buyer.

Dermapharm AG has acquired 70% of the shares in Fitvia GmbH.

We acted as advisor to the buyer.